These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30191616)

  • 1. Potential clinical implications of HPV status and expressions of p53 and cyclin D1 among oropharyngeal cancer patients.
    Lu XJD; Liu KYP; Soares RC; Thomson T; Prisman E; Wu J; Poh CF
    J Oral Pathol Med; 2018 Nov; 47(10):945-953. PubMed ID: 30191616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
    Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
    J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1-a prognostic marker in oropharyngeal squamous cell carcinoma that is tightly associated with high-risk human papillomavirus status.
    Scantlebury JB; Luo J; Thorstad WL; El-Mofty SK; Lewis JS
    Hum Pathol; 2013 Aug; 44(8):1672-80. PubMed ID: 23566410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of p16 and p53 expression in oropharyngeal squamous cell carcinomas.
    Shinohara S; Kikuchi M; Tona R; Kanazawa Y; Kishimoto I; Harada H; Imai Y; Usami Y
    Jpn J Clin Oncol; 2014 Mar; 44(3):232-40. PubMed ID: 24470584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between clinical factors, p16, and cyclin-D1 expression and survival outcomes in oropharyngeal and hypopharyngeal squamous cell carcinoma.
    Ang SH; Haaland B; Acharyya S; Thu MM; Krisna SS; Hwang SG; Tan PH; Ng QS; Tan DS; Tai WM; Tan EH; Lim WT; Ang MK
    Head Neck; 2015 Nov; 37(11):1650-9. PubMed ID: 24953865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus, p53 and cyclin D1 expression in oropharyngeal carcinoma.
    Kumar RV; Kadkol SS; Daniel R; Shenoy AM; Shah KV
    Int J Oral Maxillofac Surg; 2003 Oct; 32(5):539-43. PubMed ID: 14759115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of p16, p53, epidermal growth factor receptor, and human papillomavirus in oropharyngeal cancer in a betel nut-chewing area.
    Al-Swiahb JN; Huang CC; Fang FM; Chuang HC; Huang HY; Luo SD; Chen CH; Chen CM; Chien CY
    Arch Otolaryngol Head Neck Surg; 2010 May; 136(5):502-8. PubMed ID: 20479383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of p53, p16(INK4a), pRb and Cyclin D1 expression and human papillomavirus in primary ovarian serous carcinomas.
    Bilyk OO; Pande NT; Buchynska LG
    Exp Oncol; 2011 Sep; 33(3):150-6. PubMed ID: 21956468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From HPV-positive towards HPV-driven oropharyngeal squamous cell carcinomas.
    Boscolo-Rizzo P; Pawlita M; Holzinger D
    Cancer Treat Rev; 2016 Jan; 42():24-9. PubMed ID: 26547133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of cyclin D1 in conjunction with human papillomavirus status to predict outcome in oropharyngeal cancer.
    Hong AM; Dobbins TA; Lee CS; Jones D; Fei J; Clark JR; Armstrong BK; Harnett GB; Milross CG; Tran N; Peculis LD; Ng C; Milne AG; Loo C; Hughes LJ; Forstner DF; O'Brien CJ; Rose BR
    Int J Cancer; 2011 Apr; 128(7):1532-45. PubMed ID: 20503270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.
    Ukpo OC; Flanagan JJ; Ma XJ; Luo Y; Thorstad WL; Lewis JS
    Am J Surg Pathol; 2011 Sep; 35(9):1343-50. PubMed ID: 21836494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinoma.
    Perisanidis C; Perisanidis B; Wrba F; Brandstetter A; El Gazzar S; Papadogeorgakis N; Seemann R; Ewers R; Kyzas PA; Filipits M
    J Oral Pathol Med; 2012 Jan; 41(1):40-6. PubMed ID: 21883486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic and predictive value of koilocytosis, expression of e6 hpv types 16/18, p16ink4a, p53 in locally advanced squamous cell carcinomas of oral cavity and oropharynx, associated with human papillomavirus].
    Riaboshapka AN
    Georgian Med News; 2014 Nov; (236):48-55. PubMed ID: 25541826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of human papillomavirus status, survivin, and epidermal growth factor receptor expression on survival in patients treated with radiochemotherapy for very advanced nonresectable oropharyngeal cancer.
    Semrau R; Duerbaum H; Temming S; Huebbers C; Stenner M; Drebber U; Klussmann JP; Müller RP; Preuss SF
    Head Neck; 2013 Sep; 35(9):1339-44. PubMed ID: 23042483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-category remains an important prognostic factor for oropharyngeal carcinoma in the era of human papillomavirus.
    Mackenzie P; Pryor D; Burmeister E; Foote M; Panizza B; Burmeister B; Porceddu S
    Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):643-7. PubMed ID: 25001635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma.
    Wilczynski SP; Lin BT; Xie Y; Paz IB
    Am J Pathol; 1998 Jan; 152(1):145-56. PubMed ID: 9422532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papilloma virus and survival of oropharyngeal cancer patients treated with surgery and adjuvant radiotherapy.
    Broglie MA; Soltermann A; Haile SR; Huber GF; Stoeckli SJ
    Eur Arch Otorhinolaryngol; 2015 Jul; 272(7):1755-62. PubMed ID: 24880469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 overexpression is associated with poor prognosis in oropharyngeal cancer.
    Lin RJ; Lubpairee T; Liu KY; Anderson DW; Durham S; Poh CF
    J Otolaryngol Head Neck Surg; 2013 Mar; 42(1):23. PubMed ID: 23672832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
    Lohaus F; Linge A; Tinhofer I; Budach V; Gkika E; Stuschke M; Balermpas P; Rödel C; Avlar M; Grosu AL; Abdollahi A; Debus J; Bayer C; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; von Neubeck C; Baretton GB; Löck S; Thames HD; Krause M; Baumann M;
    Radiother Oncol; 2014 Dec; 113(3):317-23. PubMed ID: 25480095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.